Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

L.A. McKeown

December 22, 2022

News Conference News AHA 2022

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Michael O'Riordan

November 06, 2022

News Conference News AHA 2022

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Michael O'Riordan

November 06, 2022

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

News Daily News

Low-Carb Diet Promising for Lowering Blood Sugar in Prediabetes

L.A. McKeown

October 28, 2022

News Daily News

Checking Cumulative High BP Exposure Hones CV Risk Prediction in Diabetes

Todd Neale

September 14, 2022

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

L.A. McKeown

August 30, 2022

News Daily News

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

Shelley Wood

August 23, 2022

News Daily News

CV Risk Factor Control Cuts Post-op Nursing Home Transfer for Black Americans

Yael L. Maxwell

July 22, 2022

News Daily News

CVD, Diabetes Spike in Acute Phase of COVID-19

Todd Neale

July 19, 2022

News Daily News

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

Michael O'Riordan

July 05, 2022

News Conference News ESC Heart Failure 2022

Dapagliflozin Boosts Health Status Across LVEF Range

Shelley Wood

May 23, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Daily News

Strength Training Linked to Less Premature Mortality, CVD, and Diabetes

Michael O'Riordan

March 02, 2022

News Daily News

GRACE Performs Poorly in Ethnic Minorities With NSTEMI, Study Finds

L.A. McKeown

March 01, 2022

News Daily News

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Michael O'Riordan

February 18, 2022

News Daily News

Poor Prepregnancy Cardiometabolic Health Observed Across the US

Yael L. Maxwell

February 14, 2022

Advertisement

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Low-Carb Diet Promising for Lowering Blood Sugar in Prediabetes

Checking Cumulative High BP Exposure Hones CV Risk Prediction in Diabetes

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

CV Risk Factor Control Cuts Post-op Nursing Home Transfer for Black Americans

CVD, Diabetes Spike in Acute Phase of COVID-19

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

Dapagliflozin Boosts Health Status Across LVEF Range

Good News and Bad for High-Intensity Statin Use in ASCVD

Strength Training Linked to Less Premature Mortality, CVD, and Diabetes

GRACE Performs Poorly in Ethnic Minorities With NSTEMI, Study Finds

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Poor Prepregnancy Cardiometabolic Health Observed Across the US

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content